Mineralys Therapeutics, Inc. (MLYS) has 12 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Slingsby Brian Taylor mit 8,903,838 Aktien. Weitere bedeutende Anteilseigner sind RA CAPITAL MANAGEMENT, L.P. und Samsara BioCapital GP, LLC.
In den letzten 12 Monaten haben Insider 37 Transaktionen in MLYS Aktien getätigt — 13 Käufe (im Wert von $19.01M) und 10 Verkäufe (im Wert von $1.81M). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
MLYS Insider-Beteiligungen
Größter Aktionär
Slingsby Brian Taylor
8,903,838 Aktien
Käufe (12 Monate)
13
$19.01M Wert
Verkäufe (12 Monate)
10
$1.81M Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Slingsby Brian Taylor |
10 Percent Owner |
8,903,838 |
2025-04-25 |
|
| 2 |
Ra Capital Management, L.p. |
Director |
5,767,221 |
2026-03-31 |
|
| 3 |
Samsara Biocapital Gp, Llc |
10 Percent Owner |
5,674,916 |
2025-03-17 |
|
| 4 |
Congleton Jon |
Chief Executive Officer |
705,051 |
2026-04-02 |
|
| 5 |
Levy Adam Scott |
CFO and Secretary |
48,538 |
2026-02-20 |
|
| 6 |
Litzka Olivier |
Director |
22,000 |
2024-05-23 |
|
| 7 |
Dirocco Derek |
Director |
6,200 |
2026-02-20 |
|
| 8 |
Sblendorio Glenn |
Director |
6,200 |
2026-02-20 |
|
| 9 |
Karydas Daphne |
Director |
6,200 |
2026-04-02 |
|
| 10 |
Gold Alexander M |
Director |
6,200 |
2026-02-20 |
|
| 11 |
Akkaraju Srinivas |
10 Percent Owner |
6,200 |
2026-02-20 |
|
| 12 |
Rodman David Malcom |
Chief Medical Officer |
5,000 |
2026-03-17 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-03-31 |
Karydas Daphne |
Director |
Informierter Verkauf |
3,000 |
$25.00 |
$75K |
| 2026-03-31 |
Congleton Jon |
Chief Executive Officer |
Informierter Verkauf |
453 |
$27.05 |
$12.25K |
| 2026-03-30 |
Ra Capital Management, L.p. |
Director |
Informierter Kauf |
58,300 |
$24.16 |
$1.41M |
| 2026-03-27 |
Ra Capital Management, L.p. |
Director |
Informierter Kauf |
310,700 |
$23.67 |
$7.35M |
| 2026-03-17 |
Rodman David Malcom |
Chief Medical Officer |
Optionsausübung (Verkauf) |
417 |
$15.44 |
$6.44K |
| 2026-03-13 |
Rodman David Malcom |
Chief Medical Officer |
Informierter Verkauf |
253 |
$27.82 |
$7.04K |
| 2026-03-12 |
Rodman David Malcom |
Chief Medical Officer |
Optionsausübung (Verkauf) |
6,348 |
$1.08 |
$6.86K |
| 2026-03-09 |
Rodman David Malcom |
Chief Medical Officer |
Optionsausübung (Verkauf) |
2,171 |
$16.00 |
$34.74K |
| 2026-03-04 |
Warren Eric |
Chief Commercial Officer |
Unbekannt |
357,000 |
$13.24 |
$4.73M |
| 2026-02-19 |
Gold Alexander M |
Director |
RSU-Zuteilung |
6,200 |
- |
- |
| 2026-02-19 |
Slingsby Brian Taylor |
10 Percent Owner |
Sonstige (Verkauf) |
6,200 |
- |
- |
| 2026-02-19 |
Karydas Daphne |
Director |
RSU-Zuteilung |
6,200 |
- |
- |
| 2026-02-19 |
Dirocco Derek |
Director |
RSU-Zuteilung |
6,200 |
- |
- |
| 2026-02-19 |
Levy Adam Scott |
CFO and Secretary |
RSU-Zuteilung |
39,900 |
- |
- |
| 2026-02-19 |
Rodman David Malcom |
Chief Medical Officer |
RSU-Zuteilung |
51,300 |
$28.06 |
$1.44M |
| 2026-02-19 |
Congleton Jon |
Chief Executive Officer |
RSU-Zuteilung |
187,900 |
$28.06 |
$5.27M |
| 2026-02-19 |
Ra Capital Management, L.p. |
Director |
RSU-Zuteilung |
6,200 |
- |
- |
| 2026-02-19 |
Sblendorio Glenn |
Director |
RSU-Zuteilung |
6,200 |
- |
- |
| 2026-02-19 |
Akkaraju Srinivas |
10 Percent Owner |
RSU-Zuteilung |
6,200 |
- |
- |
| 2026-02-17 |
Rodman David Malcom |
Chief Medical Officer |
Optionsausübung (Verkauf) |
417 |
$15.44 |
$6.44K |
| 2026-02-13 |
Rodman David Malcom |
Chief Medical Officer |
Informierter Verkauf |
6,348 |
$27.58 |
$175.1K |
| 2026-02-12 |
Rodman David Malcom |
Chief Medical Officer |
Optionsausübung (Verkauf) |
6,349 |
$1.08 |
$6.86K |
| 2026-02-09 |
Rodman David Malcom |
Chief Medical Officer |
Optionsausübung (Verkauf) |
2,171 |
$16.00 |
$34.74K |
| 2026-01-20 |
Rodman David Malcom |
Chief Medical Officer |
Optionsausübung (Verkauf) |
416 |
$15.44 |
$6.42K |
| 2026-01-14 |
Rodman David Malcom |
Chief Medical Officer |
Informierter Verkauf |
11,367 |
$32.61 |
$370.64K |
